Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Clinical trial NCT00542022 · COMPLETED

Trial details

NCT number: NCT00542022
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2004-06-01
Primary completion: 2005-05-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.